Financial Data and Key Metrics Changes - For the first time since 2021, the company achieved full year net sales growth of $613.5 million, representing a 1.9% increase compared to fiscal 2024, with core net sales growth of 6.6% driven by 3.8% volume growth and 2.8% from pricing [7][30] - Adjusted EBITDA margins exceeded 20% for the first time since 2021, with adjusted EBITDA for the year reaching $124 million, up $13.5 million from 2024 [21][32] - Fourth quarter net sales increased by 10.9% year-over-year to $155.4 million, with core growth of 13.5%, marking the strongest core growth performance of 2025 [8][23] Business Line Data and Key Metrics Changes - American Performance division saw a 10% year-over-year increase, while Truck & Off-Road grew by 5.4%, Euro & Import maintained strong momentum with a 21.5% increase, and Safety & Racing closed the quarter up 13.3% [11] - New product launches contributed approximately $23 million in sales for the year, highlighting the ongoing vitality of the company's portfolio [9] Market Data and Key Metrics Changes - The company reported broad-based growth across both B2B and direct-to-consumer channels, reflecting the strength and diversification of its portfolio [5][30] - The market growth for 2025 was estimated at 3%-4%, with the company continuing to gain market share [40] Company Strategy and Development Direction - The strategic framework focuses on three priorities: fueling teammates, strengthening customer relationships, and accelerating profitable growth, which guided decision-making throughout 2025 [12][36] - The company plans to expand its performance chemicals portfolio and enhance digital merchandising while continuing to optimize product launch processes [17][34] Management's Comments on Operating Environment and Future Outlook - The management noted that the consumer backdrop remains uneven, with middle and lower-income households facing pressure, while higher-income consumers are more willing to spend [33] - For 2026, the company expects revenue in the range of $625 million to $655 million, implying approximately 4%-4.5% growth at the midpoint [33] Other Important Information - The company generated $34.2 million of free cash flow for the year, marking its third consecutive year of positive cash generation [27] - Total debt prepayments reached $100 million since September 2023, with leverage reduced to below 3.8x [8][20] Q&A Session Summary Question: Can you quantify market growth in 2025 and expectations for 2026? - Management indicated that market growth last year was in the 3%-4% range, with expectations for continued share gains in 2026, albeit at a slower pace [40] Question: What is the timing and frequency of pricing increases? - The company typically implements pricing increases mid-year, with a modest price increase taken at the beginning of the year, but no significant increases anticipated for 2026 [42][43] Question: How does the company view elasticity and unit trends in relation to tariffs? - Management acknowledged some volume implications due to tariffs but emphasized a focus on surgical pricing actions to maintain margins and free cash flow [48] Question: Are any business segments more cyclical than others? - The Euro & Import segment showed robust growth, indicating that affluent buyers are less sensitive to economic pressures, while overall health across the portfolio was noted [60] Question: Can you provide details on the ERP and WMS system implementation? - The implementation is primarily focused on preparation in 2026, with a go-live expected in early 2027, and the company aims to avoid any business impact during this transition [69]